AECI Ltd (87FZ)
London Exchange · UK · prices in GBX · close of 15 Oct 2026
Key indicators
| Last close | GBX 65.75 |
|---|---|
| 52-week range | 65.64 – 65.75 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.2% / +0.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 100 |
| Volatility (1 year) | 0.1% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.00M GBX |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AECI Ltd is a South African chemicals group that supplies explosives and blasting services to mining companies, along with specialty chemicals and related services for industrial customers. Its operations span mining, manufacturing and other sectors, and the company is based in South Africa, where it serves customers locally and in other markets. AECI provides chemical products and technical services rather than consumer goods, working mainly with businesses in mining and industry.
AECI Ltd trades under the code 87FZ on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AECI Ltd (87FZ) trades on the London Exchange in UK. It last closed at GBX 65.75 on 15 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,395 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.2% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | 0.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 0.2% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 0.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M GBX | ||
| Zero-volume days | 100.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +0.0% |
| 1 year | +0.2% |
| 3 years | +0.4% |
| 5 years | +0.6% |
Signals
| 50-day / 200-day average | 65.75 / 65.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | GBP 0.0275 |
| 1 Apr 2026 | GBP 0.0582 |
| 10 Dec 2025 | GBP 0.0275 |
| 28 Aug 2025 | GBP 0.0441 |
| 5 Jun 2025 | GBP 0.0275 |
| 5 Dec 2024 | GBP 0.0275 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.